Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Deckers Brands to Present at Upcoming Conferences
GOLETA, Calif.--(BUSINESS WIRE)--Deckers Brands (NYSE:DECK), a global leader in designing, marketing and…
